Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Edentulism: later-stage trial registry
3 of 5 indexed Edentulism trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Edentulism: 5 US clinical trials tracked, 3 recruiting.
Edentulism is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Dentsply International, running 1 of these trials.
Enrollment posture brief
Registry condition edentulism
OPEN 3 | RECR 60% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Edentulism lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Edentulism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Edentulism is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Edentulism research.
Dentsply International accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Edentulism trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Edentulism research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
CeraRoot SL
NCT06287346
Dental Implant Healing With TNF-Alpha Inhibitors
University of Pennsylvania
NCT06538870
Platelet-Rich Fibrinogen in Extraction Socket Healing of the Aged
University of Nebraska
NCT06943846
Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone
Dentsply Sirona Implants and Consumables
NCT00807456
Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses
Dentsply International
NCT00780273
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Edentulism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Edentulism trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Edentulism page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Edentulism trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dentsply International sponsors the most Edentulism trials on record, review their full trial history before evaluating a specific study. See Dentsply International's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Edentulism condition card totals 5 registered trials; most-linked intervention Biomet 3i Prevail Implants; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.